Occult hepatitis B infection in patients infected with HIV: Report of two cases of hepatitis B reactivation and prevalence in a hospital cohort, Journal of Medical Virology, vol.78, issue.2, pp.206-218 ,
DOI : 10.1002/jmv.21685
Virologie médicale, 2002. ,
SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTS, Journal of Hepatology, vol.42, issue.5, pp.615-639, 2005. ,
DOI : 10.1016/j.jhep.2005.03.003
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine, Hepatology, vol.15, issue.6, pp.1670-1677, 1998. ,
DOI : 10.1002/hep.510270628
Hepatitis B virus: the genotype E puzzle, Reviews in Medical Virology, vol.37, issue.8-9, pp.231-271, 2009. ,
DOI : 10.1080/00034983.1954.11685622
Occult hepatitis B virus infection in HIV-infected patients: Evaluation of biochemical, virological and molecular parameters, Hepatology Research, vol.73, issue.2, pp.1194-203, 2008. ,
DOI : 10.1016/0016-5085(90)91035-5
Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America, Journal of General Virology, vol.41, issue.8, pp.2059-73, 2002. ,
DOI : 10.1172/JCI115500
Hepatitis B Vaccination and the Risk of Multiple Sclerosis, New England Journal of Medicine, vol.344, issue.5, pp.327-359, 2001. ,
DOI : 10.1056/NEJM200102013440502
Detection of additional antigenic determinants of hepatitis B antigen, J Immunol, vol.109, issue.4, pp.842-850, 1972. ,
Ninety???Six???Week Efficacy of Combination Therapy with Lamivudine and Tenofovir in Patients Coinfected with HIV???1 and Wild???Type Hepatitis B Virus, Clinical Infectious Diseases, vol.39, issue.7, pp.1062-1066, 2004. ,
DOI : 10.1097/00002030-200301030-00002
Hepatitis B virus mutations associated with antiviral therapy, Journal of Medical Virology, vol.38, issue.S1, pp.52-57, 2006. ,
DOI : 10.1002/jmv.20608
Hepatitis B virus replication, World Journal of Gastroenterology, vol.13, issue.1, pp.48-64, 2007. ,
DOI : 10.3748/wjg.v13.i1.48
Hepatitis B in the HIV-Coinfected Patient, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.45, issue.Supplement 2, pp.57-65, 2007. ,
DOI : 10.1097/QAI.0b013e318068d1dd
Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients, The Lancet, vol.345, issue.8946, pp.396-403, 1995. ,
DOI : 10.1016/S0140-6736(95)90388-7
Occult hepatitis B infection in patients infected with HIV: Report of two cases of hepatitis B reactivation and prevalence in a hospital cohort, Journal of Medical Virology, vol.78, issue.2, pp.206-218 ,
DOI : 10.1002/jmv.21685
The Influence of Human Immunodeficiency Virus Type 1 Infection on the Development of the Hepatitis B Virus Carrier State, Journal of Infectious Diseases, vol.163, issue.5, pp.1138-1178, 1991. ,
DOI : 10.1093/infdis/163.5.1138
Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials, Journal of Hepatology, vol.47, issue.4, pp.492-500, 2007. ,
DOI : 10.1016/j.jhep.2007.06.011
YMDD-mutant HBV strain as a cause of liver failure in an HIV-infected patient, Gastroenterology, vol.121, issue.4, pp.1027-1035, 2001. ,
DOI : 10.1053/gast.2001.28586
Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker, European Journal of Clinical Microbiology & Infectious Diseases, vol.188, issue.7, pp.492-496, 2005. ,
DOI : 10.7326/0003-4819-101-6-795
A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B, New England Journal of Medicine, vol.354, issue.10, pp.1001-1011, 2006. ,
DOI : 10.1056/NEJMoa051285
Genotypic dominance and novel recombinations in HBV genotype B and C co-infected intravenous drug users, Journal of Medical Virology, vol.61, issue.1, pp.13-22, 2004. ,
DOI : 10.1099/0022-1317-82-4-883
Chemokine expression during development of fibrosis versus resolution in a murine model of granulomatous experimental autoimmune thyroiditis, Journal of Leukocyte Biology, vol.150, issue.3, pp.716-740, 2005. ,
DOI : 10.1530/eje.0.1500225
Detection of hepatitis B surface antigen, hepatitis B core antigen, and hepatitis B virus DNA in parotid tissues, International Journal of Infectious Diseases, vol.13, issue.1, pp.20-23, 2009. ,
DOI : 10.1016/j.ijid.2008.03.015
Evaluation of the Abbott RealTime HBV DNA Assay and Comparison to the Cobas AmpliPrep/Cobas TaqMan 48 Assay in Monitoring Patients with Chronic Cases of Hepatitis B, Journal of Clinical Microbiology, vol.46, issue.4, pp.1517-1526, 2008. ,
DOI : 10.1128/JCM.02046-07
Reactivation of latent hepatitis B virus infection with HIV-related immunosuppression, International Journal of STD & AIDS, vol.17, issue.1, pp.67-76, 2006. ,
DOI : 10.1258/095646206775220612
Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy, Journal of Medical Virology, vol.18, issue.3, pp.441-446, 2009. ,
DOI : 10.1002/jmv.21422
Four years assessment of entecavir resistance in nucleoside-naive and lamivudine refractory patients, J Hepatol, vol.1, p.294, 2007. ,
Vaccinations and the Risk of Relapse in Multiple Sclerosis, New England Journal of Medicine, vol.344, issue.5, pp.319-345, 2001. ,
DOI : 10.1056/NEJM200102013440501
Efficacy and tolerability of long-term therapy using high lamivudine doses for the treatment of chronic hepatitis B, Journal of Gastroenterology, vol.36, issue.7, pp.476-85, 2001. ,
DOI : 10.1007/s005350170071
Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers, Journal of Medical Virology, vol.36, issue.1, pp.53-62, 2006. ,
DOI : 10.1099/0022-1317-81-5-1165
The Hepatitis B Virus Polymerase Mutation rtV173L Is Selected during Lamivudine Therapy and Enhances Viral Replication In Vitro, Journal of Virology, vol.77, issue.21, pp.11833-11874, 2003. ,
DOI : 10.1128/JVI.77.21.11833-11841.2003
Durability of serologic response after lamivudine treatment of chronic hepatitis B, Hepatology, vol.9, issue.4, pp.748-55, 2003. ,
DOI : 10.1046/j.1365-2893.2002.00357.x
Novel Alpha Interferon (IFN-??) Variant with Improved Inhibitory Activity against Hepatitis C Virus Genotype 1 Replication Compared to IFN-??2b Therapy in a Subgenomic Replicon System, Antimicrobial Agents and Chemotherapy, vol.50, issue.12, pp.3984-91, 2006. ,
DOI : 10.1128/AAC.00199-06
URL : https://hal.archives-ouvertes.fr/inserm-00134586
Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy, AIDS, vol.20, issue.9, pp.1253-60, 2006. ,
DOI : 10.1097/01.aids.0000232232.41877.2a
Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains, J Clin Microbiol, vol.38, issue.9, pp.3311-3317, 2000. ,
Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients<SUBTITLE>A 3-Year Randomized Trial</SUBTITLE>, JAMA, vol.292, issue.2, pp.191-201, 2004. ,
DOI : 10.1001/jama.292.2.191
Hepatitis B Virus Infection ??? Natural History and Clinical Consequences, New England Journal of Medicine, vol.350, issue.11, pp.1118-1147, 2004. ,
DOI : 10.1056/NEJMra031087
Permanent loss of anti-HBc after reactivation of hepatitis B virus infection in an anti-HBs and anti-HBc-positive patient after allogeneic stem cell transplantation, Journal of Clinical Virology, vol.38, issue.2, pp.146-154, 2007. ,
DOI : 10.1016/j.jcv.2006.03.014
Mutation rate of the hepadnavirus genome, Virology, vol.170, issue.2, pp.595-602, 1989. ,
DOI : 10.1016/0042-6822(89)90455-8
Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: A two-year study, Journal of Hepatology, vol.43, issue.1, pp.60-66, 2005. ,
DOI : 10.1016/j.jhep.2005.02.017
Recent advances in hepatitis B virus research: A German point of view, World Journal of Gastroenterology, vol.13, issue.1, pp.8-13, 2007. ,
DOI : 10.3748/wjg.v13.i1.8
Efficient Inhibition of Hepatitis B Virus Infection by Acylated Peptides Derived from the Large Viral Surface Protein, Journal of Virology, vol.79, issue.3, pp.1613-1635, 2005. ,
DOI : 10.1128/JVI.79.3.1613-1622.2005
Genetic variation in HBV infection: genotypes and mutants, Journal of Clinical Virology, vol.36, issue.1, pp.3-11, 2006. ,
DOI : 10.1016/S1386-6532(06)80002-8
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen???Negative Chronic Hepatitis B, New England Journal of Medicine, vol.348, issue.9, pp.800-807, 2003. ,
DOI : 10.1056/NEJMoa021812
Reappearance of hepatitis B surface antigen in immunocompromised individuals: reinfection or reactivation?, Digestive Diseases and Sciences, vol.47, issue.2, pp.415-423, 2002. ,
DOI : 10.1023/A:1013794711235
Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only, European Journal of Clinical Microbiology & Infectious Diseases, vol.172, issue.1, pp.6-13, 1998. ,
DOI : 10.1007/BF01584356
Traité de virologie médicale INVS Calendrier vaccinal, 2003. ,
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial, The Lancet, vol.365, issue.9454, pp.123-132, 2005. ,
DOI : 10.1016/S0140-6736(05)17701-0
Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays, Journal of Medical Virology, vol.60, issue.4, pp.508-523, 2004. ,
DOI : 10.1099/0022-1317-81-5-1165
Occult Hepatitis B Virus Infection and Clinical Outcomes of Patients with Chronic Hepatitis C, Journal of Clinical Microbiology, vol.40, issue.11, pp.4068-71, 2002. ,
DOI : 10.1128/JCM.40.11.4068-4071.2002
Viruses and interferon: a fight for supremacy, Nature Reviews Immunology, vol.6, issue.9, pp.675-87, 2002. ,
DOI : 10.1038/11737
Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers, Journal of Hepatology, vol.34, issue.4, pp.584-590, 2001. ,
DOI : 10.1016/S0168-8278(00)00023-4
Predominance of genotype A HBV in an HBV-HIV-1 dually positive population compared with an HIV-1-negative counterpart in Japan, Journal of Medical Virology, vol.58, issue.4, pp.435-475, 2001. ,
DOI : 10.1002/(SICI)1096-9071(199906)58:2<105::AID-JMV1>3.0.CO;2-3
Hepatitis B Virus HBx Gene and Hepatocarcinogenesis, Intervirology, vol.38, issue.3-4, pp.3-4, 1995. ,
DOI : 10.1159/000150424
Long-Term Remission of Chronic Hepatitis B after Alpha-Interferon Therapy, Annals of Internal Medicine, vol.114, issue.8, pp.629-663, 1991. ,
DOI : 10.7326/0003-4819-114-8-629
Long-term hepatitis B virus dynamics in HIV???hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate, AIDS, vol.19, issue.9, pp.907-922, 2005. ,
DOI : 10.1097/01.aids.0000171404.07995.5c
Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV, AIDS, vol.20, issue.3, pp.419-446, 2006. ,
DOI : 10.1097/01.aids.0000200537.86984.0e
Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial, Hepatology, vol.25, issue.1, pp.241-245, 1997. ,
DOI : 10.1002/hep.510250144
Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B, New England Journal of Medicine, vol.357, issue.25, pp.2576-88, 2007. ,
DOI : 10.1056/NEJMoa066422
Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B, New England Journal of Medicine, vol.354, issue.10, pp.1011-1031, 2006. ,
DOI : 10.1056/NEJMoa051287
Inhibition of Hepatitis B Virus Polymerase by Entecavir, Journal of Virology, vol.81, issue.8, pp.3992-4001, 2007. ,
DOI : 10.1128/JVI.02395-06
The Heterogeneity of Australia Antigen, Journal of Infectious Diseases, vol.123, issue.6, pp.671-676, 1971. ,
DOI : 10.1093/infdis/123.6.671
Clevudine Demonstrates Potent Antiviral Activity in Na??ve Chronic Hepatitis B Patients, Intervirology, vol.53, issue.2, pp.83-89, 2009. ,
DOI : 10.1159/000264197
No benefit to continue lamivudine therapy after emergence of YMDD mutations, Antivir Ther, vol.9, issue.2, pp.257-62, 2004. ,
Hepatitis B virus infection, The Lancet, vol.373, issue.9663, pp.582-92, 2009. ,
DOI : 10.1016/S0140-6736(09)60207-5
2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B, Gastroenterology, vol.136, issue.2, pp.486-95, 2009. ,
DOI : 10.1053/j.gastro.2008.10.026
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease, New England Journal of Medicine, vol.351, issue.15, pp.1521-1552, 2004. ,
DOI : 10.1056/NEJMoa033364
Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients, J Acquir Immune Defic Syndr, vol.44, issue.3, pp.315-335, 2007. ,
Molecular Virology of Hepatitis B Virus, Seminars in Liver Disease, vol.24, issue.1, pp.3-10, 2004. ,
DOI : 10.1055/s-2004-828672
Management of antiviral resistance in patients with chronic hepatitis B, Antivir Ther, vol.9, issue.5, pp.679-93, 2004. ,
Long-term safety of lamivudine treatment in patients with chronic hepatitis B, Gastroenterology, vol.125, issue.6, pp.1714-1736, 2003. ,
DOI : 10.1053/j.gastro.2003.09.033
Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital, Journal of Medical Virology, vol.30, issue.3, pp.406-418, 2009. ,
DOI : 10.1093/infdis/169.3.628
Subtypes, Genotypes and Molecular Epidemiology of the Hepatitis B Virus as Reflected by Sequence Variability of the S-Gene, Intervirology, vol.38, issue.1-2, pp.24-34, 1995. ,
DOI : 10.1159/000150411
Virologie médicale, 2002. ,
Reactivation of Hepatitis B Virus Replication Accompanied by Acute Hepatitis in Patients Receiving Highly Active Antiretroviral Therapy, Clinical Infectious Diseases, vol.349, issue.9063, pp.144-152, 2001. ,
DOI : 10.1016/S0140-6736(96)11431-8
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B, New England Journal of Medicine, vol.359, issue.23, pp.2442-55, 2008. ,
DOI : 10.1056/NEJMoa0802878
IMMUNISATION AGAINST HEPATITIS B IN MAN, The Lancet, vol.307, issue.7974, pp.1367-70, 1976. ,
DOI : 10.1016/S0140-6736(76)93023-3
Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?, Journal of Viral Hepatitis, vol.6, issue.4, pp.299-304, 1999. ,
DOI : 10.1136/gut.19.11.1022
Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients, Hepatology, vol.37, issue.Suppl 2, pp.1151-1158, 2009. ,
DOI : 10.1053/jhep.2003.50148
Low Genetic Diversity despite Hyperendemicity of Hepatitis B Virus Genotype E throughout West Africa, The Journal of Infectious Diseases, vol.190, issue.2, pp.400-408, 2004. ,
DOI : 10.1086/421502
Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, Clin Infect Dis, vol.40, issue.5, pp.2002-2003, 2005. ,
Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons, Journal of Medical Virology, vol.64, issue.10, pp.1464-71, 2007. ,
DOI : 10.1002/jmv.20954
An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals, AIDS, vol.17, issue.1, pp.7-10, 2003. ,
DOI : 10.1097/00002030-200301030-00002
Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B, New England Journal of Medicine, vol.334, issue.22, pp.1422-1429, 1996. ,
DOI : 10.1056/NEJM199605303342202
Lack of ???occult??? hepatitis B virus infection in HIV-infected patients, AIDS, vol.16, issue.15, pp.2099-101, 2002. ,
DOI : 10.1097/00002030-200210180-00024
Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr, J Virol, issue.10, pp.61-3030, 1987. ,
Multiple genotypes and subtypes of hepatitis B and C viruses in Belarus: similarities with Russia and western European influences, Clinical Microbiology and Infection, vol.14, issue.6, 2008. ,
DOI : 10.1111/j.1469-0691.2008.01988.x
Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations, Journal of General Virology, vol.87, issue.5, pp.1163-73, 2006. ,
DOI : 10.1099/vir.0.81614-0
Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients, World Journal of Gastroenterology, vol.15, issue.6, pp.753-758, 2009. ,
DOI : 10.3748/wjg.15.753
Factors influencing response to interferon in chronic hepatitis B: Implications for Asian and western populations, Hepatology, vol.85, issue.6, pp.1433-1438, 1990. ,
DOI : 10.1093/infdis/143.6.772
Diagnosis and management of hepatitis B virus and HIV coinfection, Top HIV Med, vol.15, issue.5, pp.163-169, 2007. ,
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary???s Hospital, London, England); C. Trepo (Hopital H??tel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ)., Gastroenterology, vol.126, issue.1, pp.91-101, 2004. ,
DOI : 10.1053/j.gastro.2003.10.051
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein, Nature Biotechnology, vol.46, issue.3, pp.335-376, 2008. ,
DOI : 10.1093/oxfordjournals.molbev.a026417
The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients, Journal of Hepatology, vol.36, issue.5, pp.681-687, 2002. ,
DOI : 10.1016/S0168-8278(02)00019-3
Occult hepatitis B in HIV-HCV coinfected patients, Scandinavian Journal of Infectious Diseases, vol.40, issue.10, pp.835-844, 2008. ,
DOI : 10.1080/00365540801918511
Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma, Hepatology, vol.78, issue.2, pp.277-85, 2007. ,
DOI : 10.1053/gast.2001.28586
Biological and clinical implications of HBV infection in peripheral blood mononuclear cells, Autoimmunity Reviews, vol.8, issue.1, pp.13-20, 2008. ,
DOI : 10.1016/j.autrev.2008.07.016
Occult hepatitis B virus infection, Journal of Hepatology, vol.46, issue.1, pp.160-70, 2007. ,
DOI : 10.1016/j.jhep.2006.10.007
Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients, Gastroenterology, vol.123, issue.6, pp.1848-56, 2002. ,
DOI : 10.1053/gast.2002.37041
Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1, Eur J Clin Microbiol Infect Dis, vol.22, issue.2, pp.92-100, 2003. ,
Long-term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA, Hepatology, vol.67, issue.6, pp.2080-2086, 2009. ,
DOI : 10.1212/01.wnl.0000240078.47020.5e
Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir, Antivir Ther, vol.10, issue.6, pp.727-761, 2005. ,
Mutations affecting the replication capacity of the hepatitis B virus, Journal of Viral Hepatitis, vol.70, issue.7, pp.427-461, 2006. ,
DOI : 10.1053/jhep.2003.50012
Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses, AIDS, vol.21, issue.16, pp.2253-2257, 2007. ,
DOI : 10.1097/QAD.0b013e3282f08bae
Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus, Journal of Antimicrobial Chemotherapy, vol.56, issue.6, pp.1087-93, 2005. ,
DOI : 10.1086/424012
A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness, Journal of General Virology, vol.65, issue.1, pp.67-74, 2000. ,
DOI : 10.1016/0166-0934(91)90004-J
Large-scale efficacy trials of hepatitis B vaccines in the USA: Baseline data and protocols, Journal of Medical Virology, vol.227, issue.4, pp.327-367, 1979. ,
DOI : 10.7326/0003-4819-83-4-489
New developments in antiviral therapy for chronic hepatitis B, Vox Sanguinis, vol.48, issue.3, 2009. ,
DOI : 10.1111/j.1478-3231.2008.01696.x
Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions Present, Antimicrobial Agents and Chemotherapy, vol.51, issue.3, pp.902-913, 2007. ,
DOI : 10.1128/AAC.00833-06
Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-na??ve patients is rare through 5 years of therapy, Hepatology, vol.51, issue.4 Suppl. 1, pp.1503-1517, 2009. ,
DOI : 10.1128/AAC.01440-06
Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus, J Clin Microbiol, vol.37, issue.9, pp.3013-3019, 1999. ,
Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment, Semin Liver Dis, vol.23, issue.2, pp.125-161, 2003. ,
Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literature, Journal of Hepatology, vol.18, issue.2, pp.154-62, 1993. ,
DOI : 10.1016/S0168-8278(05)80241-7
Occult hepatitis B, The Lancet Infectious Diseases, vol.2, issue.8, pp.479-86, 2002. ,
DOI : 10.1016/S1473-3099(02)00345-6
Reduced Antigenicity of the Hepatitis B Virus HBsAg Protein Arising as a Consequence of Sequence Changes in the Overlapping Polymerase Gene That Are Selected by Lamivudine Therapy, Virology, vol.293, issue.2, pp.305-318, 2002. ,
DOI : 10.1006/viro.2001.1246
Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection, Hepatology, vol.125, issue.6, pp.1421-1426, 2004. ,
DOI : 10.1016/S0016-5085(03)00939-9
chronic hepatitis B patients: A 4-year study, Journal of Gastroenterology and Hepatology, vol.46, issue.1, 2009. ,
DOI : 10.3748/wjg.v12.i15.2417
Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure, Journal of Hepatology, vol.48, issue.5, pp.747-55, 2008. ,
DOI : 10.1016/j.jhep.2008.01.027
Surveillance for acute viral hepatitis--United States, MMWR Surveill Summ, vol.56, issue.3, pp.1-24, 2005. ,
Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B, Annals of Internal Medicine, vol.119, issue.4, pp.312-335, 1993. ,
DOI : 10.7326/0003-4819-119-4-199308150-00011
Clinical Trial Results and Treatment Resistance with Lamivudine in Hepatitis B, Seminars in Liver Disease, vol.24, issue.1, pp.31-37, 2004. ,
DOI : 10.1055/s-2004-828676
Novel approaches towards conquering hepatitis B virus infection, World Journal of Gastroenterology, vol.13, issue.6, pp.830-836, 2007. ,
DOI : 10.3748/wjg.v13.i6.830
URL : http://europepmc.org/articles/pmc4065916?pdf=render
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B, Hepatology, vol.46, issue.3, pp.675-84, 2006. ,
DOI : 10.1002/hep.21282
Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovirin vitro, Hepatology, vol.34, issue.4, pp.1669-73, 1998. ,
DOI : 10.1002/hep.510280629
Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutations, Journal of Hepatology, vol.39, issue.5, pp.850-855, 2003. ,
DOI : 10.1016/S0168-8278(03)00388-X
Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic Hepatitis B virus infection, Antiviral Research, vol.64, issue.1, pp.1-15, 2004. ,
DOI : 10.1016/S0166-3542(04)00162-7
URL : https://hal.archives-ouvertes.fr/inserm-00136413
In Vitro Models for Studying Hepatitis B Virus Drug Resistance, Seminars in Liver Disease, vol.26, issue.2, pp.171-80, 2006. ,
DOI : 10.1055/s-2006-939759
Emerging drugs for hepatitis B, Expert Opinion on Emerging Drugs, vol.10, issue.2, pp.199-217, 2007. ,
DOI : 10.1016/j.jhep.2004.11.035
URL : https://hal.archives-ouvertes.fr/inserm-00162225
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues, Gastroenterology, vol.137, issue.5, pp.1593-608, 2009. ,
DOI : 10.1053/j.gastro.2009.08.063
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine, Journal of Viral Hepatitis, vol.9, issue.4, pp.278-88, 2006. ,
DOI : 10.1111/j.1572-0241.2005.41957.x
URL : https://hal.archives-ouvertes.fr/inserm-00135954
SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTS, Journal of Hepatology, vol.42, issue.5, pp.615-624, 2005. ,
DOI : 10.1016/j.jhep.2005.03.003
Ninety???Six???Week Efficacy of Combination Therapy with Lamivudine and Tenofovir in Patients Coinfected with HIV???1 and Wild???Type Hepatitis B Virus, Clinical Infectious Diseases, vol.39, issue.7, pp.1062-1064, 2004. ,
DOI : 10.1097/00002030-200301030-00002
Hepatitis B in the HIV-Coinfected Patient, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.45, issue.Supplement 2, pp.57-65, 2007. ,
DOI : 10.1097/QAI.0b013e318068d1dd
Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker, European Journal of Clinical Microbiology & Infectious Diseases, vol.188, issue.7, pp.492-494, 2005. ,
DOI : 10.7326/0003-4819-101-6-795
Clinical impact of occult HBV infections, Journal of Clinical Virology, vol.34, pp.15-21, 2005. ,
DOI : 10.1016/S1386-6532(05)80005-8
Reactivation of latent hepatitis B virus infection with HIV-related immunosuppression, International Journal of STD & AIDS, vol.17, issue.1, pp.67-69, 2006. ,
DOI : 10.1258/095646206775220612
Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy, Journal of Medical Virology, vol.18, issue.3, pp.441-445, 2009. ,
DOI : 10.1002/jmv.21422
Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers, Journal of Medical Virology, vol.36, issue.1, pp.53-59, 2006. ,
DOI : 10.1099/0022-1317-81-5-1165
Dual Efficacy of Lamivudine Treatment in Human Immunodeficiency Virus/Hepatitis B Virus???Coinfected Persons in a Randomized, Controlled Study (CAESAR), The Journal of Infectious Diseases, vol.180, issue.3, pp.607-613, 1999. ,
DOI : 10.1086/314942
Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy, AIDS, vol.20, issue.9, pp.1253-1260, 2006. ,
DOI : 10.1097/01.aids.0000232232.41877.2a
Permanent loss of anti-HBc after reactivation of hepatitis B virus infection in an anti-HBs and anti-HBc-positive patient after allogeneic stem cell transplantation, Journal of Clinical Virology, vol.38, issue.2, pp.146-148, 2007. ,
DOI : 10.1016/j.jcv.2006.03.014
Tenofovir-Based Rescue Therapy for Advanced Liver Disease in 6 Patients Coinfected with HIV and Hepatitis B Virus and Receiving Lamivudine, Clinical Infectious Diseases, vol.12, issue.1, pp.28-30, 2008. ,
DOI : 10.1002/hep.21055
Reappearance of hepatitis B surface antigen in immunocompromised individuals: Reinfection or reactivation?, Digestive Diseases and Sciences, vol.47, issue.2, pp.415-418, 2002. ,
DOI : 10.1023/A:1013794711235
Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only, European Journal of Clinical Microbiology & Infectious Diseases, vol.172, issue.1, pp.6-13, 1998. ,
DOI : 10.1007/BF01584356
Occult Hepatitis B Virus Infection and Clinical Outcomes of Patients with Chronic Hepatitis C, Journal of Clinical Microbiology, vol.40, issue.11, pp.4068-4071, 2002. ,
DOI : 10.1128/JCM.40.11.4068-4071.2002
Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients, J Acquir Immune Defic Syndr, vol.44, pp.315-320, 2007. ,
Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital, Journal of Medical Virology, vol.30, issue.3, pp.406-412, 2009. ,
DOI : 10.1093/infdis/169.3.628
Reactivation of Hepatitis B Virus Replication Accompanied by Acute Hepatitis in Patients Receiving Highly Active Antiretroviral Therapy, Clinical Infectious Diseases, vol.349, issue.9063, pp.144-148, 2001. ,
DOI : 10.1016/S0140-6736(96)11431-8
Impact of Highly Active Antiretroviral Therapy (HAART) on the Natural History of Hepatitis B Virus (HBV) and HIV Coinfection: Relationship between Prolonged Efficacy of HAART and HBV Surface and Early Antigen Seroconversion, Clinical Infectious Diseases, vol.5, issue.6, pp.624-632, 2007. ,
DOI : 10.1016/S1473-3099(05)70141-9
Occult Hepatitis B Virus Infection in HIV-Infected Patients with Isolated Antibodies to Hepatitis B Core Antigen: Aquitaine Cohort, 2002-2003, Clinical Infectious Diseases, vol.30, issue.5, pp.750-753, 2002. ,
DOI : 10.1002/hep.510300525
Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons, Journal of Medical Virology, vol.64, issue.10, pp.1464-1471, 2007. ,
DOI : 10.1002/jmv.20954
Lack of ???occult??? hepatitis B virus infection in HIV-infected patients, AIDS, vol.16, issue.15, pp.2099-2101, 2002. ,
DOI : 10.1097/00002030-200210180-00024
Possible New Hepatitis B Virus Genotype, Southeast Asia, Emerging Infectious Diseases, vol.14, issue.11, pp.1777-1780, 2008. ,
DOI : 10.3201/eid1411.080437
URL : https://wwwnc.cdc.gov/eid/article/14/11/pdfs/08-0437.pdf
Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations, Journal of General Virology, vol.87, issue.5, pp.1163-1173, 2006. ,
DOI : 10.1099/vir.0.81614-0
Diagnosis and management of hepatitis B virus and HIV coinfection, Top HIV Med, vol.15, pp.163-166, 2007. ,
The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients, Journal of Hepatology, vol.36, issue.5, pp.681-686, 2002. ,
DOI : 10.1016/S0168-8278(02)00019-3
Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV???HCV co-infected patients on HCV therapy, Journal of Hepatology, vol.49, issue.6, pp.892-898, 2008. ,
DOI : 10.1016/j.jhep.2008.06.024
Natural history of chronic hepatitis B in co-infected patients, Journal of Hepatology, vol.44, pp.65-70, 2006. ,
DOI : 10.1016/j.jhep.2005.11.015
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C, AIDS, vol.21, issue.16, pp.2171-2175, 2007. ,
DOI : 10.1097/QAD.0b013e3282eea504
Occult hepatitis B virus infection, Journal of Hepatology, vol.46, issue.1, pp.160-170, 2007. ,
DOI : 10.1016/j.jhep.2006.10.007
Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1, Eur J Clin Microbiol Infect Dis, vol.22, pp.92-98, 2003. ,
Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy, Journal of Clinical Virology, vol.39, issue.1, pp.48-50, 2007. ,
DOI : 10.1016/j.jcv.2007.01.011
Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus, Journal of Antimicrobial Chemotherapy, vol.56, issue.6, pp.1087-1093, 2005. ,
DOI : 10.1086/424012
Hepatitis B in the human immunodeficiency virusinfected patient: Epidemiology, natural history, and treatment, Semin Liver Dis, vol.23, pp.125-136, 2003. ,
Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain, Journal of Medical Virology, vol.75, issue.12, pp.1599-1608, 2006. ,
DOI : 10.1016/S0025-7753(01)71937-9